Paeds SAQs · gastroenterology-hepatology-and-nutrition
Parenteral nutrition and refeeding syndrome — formative SAQs
Two formative SAQs on parenteral nutrition and refeeding syndrome in children: a malnourished adolescent with anorexia nervosa admitted for refeeding, testing refeeding risk, the insulin-driven biochemistry, thiamine and conservative starting calories and the daily monitoring of phosphate, potassium and magnesium; and a premature infant on long-term parenteral nutrition with a rising conjugated bilirubin, testing the composition streams, the glucose infusion rate, the prevention of intestinal failure-associated liver disease and the lipid strategy.
On this page & tools
Target exams
SAQ 1 — The malnourished adolescent restarted on feeding (10 marks, 15 minutes)
A 15-year-old girl with anorexia nervosa is admitted for refeeding after six weeks of negligible intake and a 15 per cent weight loss. Her body mass index is 15. On day two of a refeeding regimen the phosphate has fallen, she is oedematous, and her heart rate is rising. [5]
a) Define refeeding syndrome and explain the biochemical mechanism by which restarting carbohydrate drives phosphate, potassium and magnesium into the cell and depletes thiamine. (3 marks) [5] [6]
b) Identify the features in this history that place her at high risk of refeeding syndrome, using the ASPEN consensus risk stratification. (2 marks) [5]
c) Outline the prevention and management you should have instituted before and during refeeding, naming thiamine, conservative starting calories, and the correction and monitoring of phosphate, potassium and magnesium. (3 marks) [5] [6]
d) Explain why she has become oedematous with a rising heart rate, and state the immediate response. (2 marks) [6]
SAQ 2 — The preterm infant with rising conjugated bilirubin (10 marks, 15 minutes)
A baby born at 27 weeks gestation has been on parenteral nutrition for four weeks for an immature gut that tolerates little milk. The lipid has been running at 3 g/kg/day from a soy-based emulsion, there have been two central-line bloodstream infections, and the conjugated bilirubin is now rising. [9]
a) Name the four parenteral streams, and give the infant targets for the glucose infusion rate, the amino acid and the lipid streams, and the energy. (3 marks) [1] [3]
b) What is the likely diagnosis for the rising conjugated bilirubin, and what are the two dominant modifiable drivers? (2 marks) [8] [9]
c) Outline the lipid and sepsis strategy to prevent and treat this condition, including the regional differences in preferred emulsion. (3 marks) [2] [8]
d) State what other diagnosis must be actively excluded in any cholestatic infant, and how. (2 marks) [8]
References
- [1]Joosten K; Embleton N; Yan W; et al ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Energy. Clin Nutr, 2018.PMID 30078715
- [2]Lapillonne A; Fidler Mis N; Goulet O; et al ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids. Clin Nutr, 2018.PMID 30143306
- [3]Mihatsch WA; Braegger C; Bronsky J; et al ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition. Clin Nutr, 2018.PMID 30471662
- [5]da Silva JSV; Seres DS; Sabino K; et al ASPEN Consensus Recommendations for Refeeding Syndrome. Nutr Clin Pract, 2020.PMID 32115791
- [6]Corsello A; Trovato CM; Dipasquale V; et al Refeeding Syndrome in Pediatric Age, An Unknown Disease: A Narrative Review. J Pediatr Gastroenterol Nutr, 2023.PMID 37705405
- [8]Lee WS; Chew KS; Ng RT; et al Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management. Hepatol Int, 2020.PMID 32356227
- [9]Fundora J; Aucott SW Intestinal Failure-Associated Liver Disease in Neonates. Neoreviews, 2020.PMID 32873652